APA (7th ed.) Citation

Ormanns, S., Siveke, J. T., Heinemann, V., Haas, M., Sipos, B., Schlitter, A. M., . . . Boeck, S. (2014). pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: A translational subgroup analysis from AIO-PK0104. BMC cancer, 14, . https://doi.org/10.1186/1471-2407-14-624

Chicago Style (17th ed.) Citation

Ormanns, Steffen, et al. "PERK, PAKT and P53 as Tissue Biomarkers in Erlotinib-treated Patients with Advanced Pancreatic Cancer: A Translational Subgroup Analysis from AIO-PK0104." BMC Cancer 14 (2014). https://doi.org/10.1186/1471-2407-14-624.

MLA (9th ed.) Citation

Ormanns, Steffen, et al. "PERK, PAKT and P53 as Tissue Biomarkers in Erlotinib-treated Patients with Advanced Pancreatic Cancer: A Translational Subgroup Analysis from AIO-PK0104." BMC Cancer, vol. 14, 2014, https://doi.org/10.1186/1471-2407-14-624.